- Home
- IMTX vs ASPI Comparison
IMTX vs ASPI Comparison
Compare IMTX & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- ASPI
- Stock Information
- Founded
- IMTX N/A
- ASPI 2021
- Country
- IMTX Germany
- ASPI United States
- Employees
- IMTX N/A
- ASPI N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- ASPI Major Chemicals
- Sector
- IMTX Health Care
- ASPI Industrials
- Exchange
- IMTX Nasdaq
- ASPI Nasdaq
- Market Cap
- IMTX 579.8M
- ASPI 470.6M
- IPO Year
- IMTX N/A
- ASPI 2022
- Fundamental
- Price
- IMTX $4.24
- ASPI $6.43
- Analyst Decision
- IMTX Strong Buy
- ASPI Strong Buy
- Analyst Count
- IMTX 4
- ASPI 2
- Target Price
- IMTX $16.67
- ASPI $4.50
- AVG Volume (30 Days)
- IMTX 426.9K
- ASPI 1.9M
- Earning Date
- IMTX 05-20-2025
- ASPI 05-19-2025
- Dividend Yield
- IMTX N/A
- ASPI N/A
- EPS Growth
- IMTX N/A
- ASPI N/A
- EPS
- IMTX 0.14
- ASPI N/A
- Revenue
- IMTX $161,336,577.00
- ASPI $4,144,225.00
- Revenue This Year
- IMTX N/A
- ASPI $690.06
- Revenue Next Year
- IMTX $4.92
- ASPI $93.09
- P/E Ratio
- IMTX $29.25
- ASPI N/A
- Revenue Growth
- IMTX 188.60
- ASPI 857.04
- 52 Week Low
- IMTX $3.30
- ASPI $1.86
- 52 Week High
- IMTX $13.77
- ASPI $9.33
- Technical
- Relative Strength Index (RSI)
- IMTX 43.11
- ASPI 64.32
- Support Level
- IMTX $3.94
- ASPI $5.16
- Resistance Level
- IMTX $5.41
- ASPI $5.95
- Average True Range (ATR)
- IMTX 0.35
- ASPI 0.43
- MACD
- IMTX -0.04
- ASPI 0.04
- Stochastic Oscillator
- IMTX 20.41
- ASPI 98.94
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. The company utilizes technology developed in South Africa over the past 20 years to enrich isotopes of elements or molecules with low atomic masses.